… We found elevated levels of these antibodies in patients with … oxLDL antibodies represent a
family of autoantibodies against … clinical impact of these autoantibodies might vary. Additional …

… of circulating anti-HSP antibodies and of T lymphocytes which are … , the risk of developing
precocious atherosclerotic lesions … antibodies is often associated with diffused atherosclerosis, …

… atherosclerosis development and manifestations, not least in women, who have a much
higher risk of autoimmune … in animal models, 100 and antibodies against PAF are associated …

… LDL predict atherosclerosis that is in … in atherosclerotic auto-antibody to oxidised LDL acts
is less plaques'"1 and it is possible that it stimulates clear. It is possible that the autoantibodies …

… These antibodies seem to be restricted to patients with SLE and APS. Thus, it can be
hypothesized that these antibodies accelerate the development of atherosclerosis in autoimmune …

… of lipids within atherosclerotic plaques. Oxidized low-density … in both autoimmune and
non-autoimmune atherosclerosis. It … patients with RA who do not have these antibodies. Similarly, …

… Atherosclerosis is always accompanied by an autoimmune response. Antibodies against …
In spite of the success of statins and PCSK9 antibodies, atherosclerosis-triggered diseases …

… between autoantibodies and atherosclerosis, amongst individuals without clinical autoimmune
… of AS-related CVDs whilst experimental data has also indicated that anti-LDL antibodies …

… Serologic proteomic studies showed circulating autoantibodies targeting structurally and
functionally related intracellular proteins involved in vital functions of cellular adherence and …

… phosphorylcholine (NPPC) whereas Group II antibodies require the phenyl group of NPPC
… anti-PC antibodies with focus on anti-inflammation in atherosclerosis. After developing a …